Adagio medical implements strategic review and trims more half its staff

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:27 UTC

Adagio Medical has initiated a strategic review of its business and will lay off more than half its full-time workers as the maker of cryoablation ablation devices faces delisting on the Nasdaq exchange.